Results 361 to 370 of about 8,234,457 (404)

Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?

Clinical drug investigation, 2017
Christiane Michel, E. Scosyrev, M. Petrin, R. Schmouder   +3 more
semanticscholar   +1 more source

DRUG SAFETY IN PORPHYRIA

The Lancet, 1980
G H, Blekkenhorst, E S, Cook, L, Eales
  +7 more sources

An overview of real‐world data sources for oncology and considerations for research

Ca-A Cancer Journal for Clinicians, 2022
Lynne Penberthy, Donna R Rivera, Jennifer L Lund, Msph   +2 more
exaly  

Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative Study

Drug Safety, 2017
A. Kesselheim, S. McGraw, Sara Z Dejene, P. Rausch, G. D. Dal Pan, B. Lappin, Esther H Zhou, J. Avorn, E. Campbell   +8 more
semanticscholar   +1 more source

Drug Safety

JAMA, 2008
openaire   +1 more source

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Analyzing research trends on drug safety using topic modeling

Expert Opinion on Drug Safety, 2018
Chen Zou
semanticscholar   +1 more source

Innovations in research and clinical care using patient‐generated health data

Ca-A Cancer Journal for Clinicians, 2020
H S L Jim, Aasha I Hoogland, Naomi C Brownstein   +2 more
exaly  

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly